June 16, 2022

Louisiana Healthcare Connections announced the opening of its Fall 2022 Community Health Grant cycle, which will invest $60,000 in grant funds for nonprofits, healthcare providers, and schools for a wide variety of health-related initiatives.

Priority will be given for applications which align with strategic priorities addressing social determinants of health, increasing preventive care, creating health equity, and improving healthy outcomes.

June 16, 2022

Baton Rouge General (BRG) is hosting a men’s screening event at its Ascension hospital as part of The Healthy Men Project, which encourages men ages 30-50 to be more proactive about their health. The screening event will take place June 25 from 8-10 a.m., and registration is required at brgeneral.org/healthymen. Launched in November, BRG has hosted Healthy Men screening events at both its Bluebonnet and Mid City campuses.

June 16, 2022

The emergency departments of Ochsner Medical Center – Baton Rouge and Ochsner Medical Complex – Iberville in Plaquemine have been named to the Emergency Quality Network Honor Roll for significant achievement in stroke treatment or opioid use disorder quality improvement metrics and performance data sharing.

Presented by the American College of Emergency Physicians, the “E-Qual” Honor Roll represents best-in-class efforts from emergency departments across the country to standardize and continuously improve the quality of patient care.

June 16, 2022

The High-Risk Breast Clinic at Baton Rouge General-Mid City was recently awarded a grant from the American Cancer Society (ACS) and the National Football League’s (NFL) Crucial Catch Project. The $20,000 grant will support the clinic, which opened last August and provides specialized care to women at risk for developing breast disease and who are underinsured or uninsured.

June 16, 2022

Pennington Biomedical Research Center faculty members Steven B. Heymsfield, MD, and Justin C. Brown, PhD, are members of a team led by the Rutgers Cancer Institute of New Jersey, Weill Cornell Medicine and Cold Spring Harbor Laboratory ­that have secured $25 million to take on the challenge of cachexia, the debilitating wasting condition responsible for up to 30 percent of cancer deaths.